These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
170 related articles for article (PubMed ID: 29571248)
1. Anti-inflammatory and anti-tumor effects of α-l-guluronic acid (G2013) on cancer-related inflammation in a murine breast cancer model. Hosseini F; Mahdian-Shakib A; Jadidi-Niaragh F; Enderami SE; Mohammadi H; Hemmatzadeh M; Mohammed HA; Anissian A; Kokhaei P; Mirshafiey A; Hassannia H Biomed Pharmacother; 2018 Feb; 98():793-800. PubMed ID: 29571248 [TBL] [Abstract][Full Text] [Related]
2. Lunasin Attenuates Obesity-Associated Metastasis of 4T1 Breast Cancer Cell through Anti-Inflammatory Property. Hsieh CC; Wang CH; Huang YS Int J Mol Sci; 2016 Dec; 17(12):. PubMed ID: 27983683 [TBL] [Abstract][Full Text] [Related]
3. Targeting of crosstalk between tumor and tumor microenvironment by β-D mannuronic acid (M2000) in murine breast cancer model. Hosseini F; Hassannia H; Mahdian-Shakib A; Jadidi-Niaragh F; Enderami SE; Fattahi M; Anissian A; Mirshafiey A; Kokhaei P Cancer Med; 2017 Mar; 6(3):640-650. PubMed ID: 28211615 [TBL] [Abstract][Full Text] [Related]
4. Plantamajoside, a potential anti-tumor herbal medicine inhibits breast cancer growth and pulmonary metastasis by decreasing the activity of matrix metalloproteinase-9 and -2. Pei S; Yang X; Wang H; Zhang H; Zhou B; Zhang D; Lin D BMC Cancer; 2015 Dec; 15():965. PubMed ID: 26674531 [TBL] [Abstract][Full Text] [Related]
5. Cucurbitacin E inhibits breast tumor metastasis by suppressing cell migration and invasion. Zhang T; Li J; Dong Y; Zhai D; Lai L; Dai F; Deng H; Chen Y; Liu M; Yi Z Breast Cancer Res Treat; 2012 Sep; 135(2):445-58. PubMed ID: 22842972 [TBL] [Abstract][Full Text] [Related]
6. Fei-Liu-Ping ointment inhibits lung cancer growth and invasion by suppressing tumor inflammatory microenvironment. Li W; Chen C; Saud SM; Geng L; Zhang G; Liu R; Hua B BMC Complement Altern Med; 2014 May; 14():153. PubMed ID: 24885825 [TBL] [Abstract][Full Text] [Related]
7. Evaluation of the Effect of α-L-Guluronic Acid (G2013) on COX-1, COX-2 Activity and Gene Expression for Introducing this Drug as a Novel NSAID with Immunomodulatory Property. Mirshafiey A; Mortazavi-Jahromi SS; Taeb M; Cuzzocrea S; Esposito E Recent Pat Inflamm Allergy Drug Discov; 2018; 12(2):162-168. PubMed ID: 29879894 [TBL] [Abstract][Full Text] [Related]
8. 2-Dodecyl-6-methoxycyclohexa-2,5-diene-1,4-dione inhibits the growth and metastasis of breast carcinoma in mice. Chen C; Nong Z; Xie Q; He J; Cai W; Tang X; Chen X; Huang R; Gao Y Sci Rep; 2017 Jul; 7(1):6704. PubMed ID: 28751740 [TBL] [Abstract][Full Text] [Related]
9. The Evaluation of Safety Property and Apoptotic Efficacy of α-L-Guluronic Acid (G2013), as a Novel NSAID, Under Hassani S; Afshari JT; Jafarnezhad-Ansariha F; Mirshafiey A Recent Adv Inflamm Allergy Drug Discov; 2022; 15(1):9-15. PubMed ID: 34503439 [TBL] [Abstract][Full Text] [Related]
11. Effect of Guluronic Acid (G2013), As a New Anti-inflammatory Drug on Gene Expression of Pro-inflammatory and Anti-inflammatory Cytokines and Their Transcription Factors in Rheumatoid Arthritis Patients. Bakhtiari T; Azarian S; Ghaderi A; Ahmadzadeh A; Mirshafiey A Iran J Allergy Asthma Immunol; 2019 Nov; 18(6):639-648. PubMed ID: 32245307 [TBL] [Abstract][Full Text] [Related]
12. Evaluation of G2013 (α-L-guluronic acid) efficacy on PC-3 cells through inhibiting the expression of inflammatory factors. Bagherian Z; Mirshafiey A; Mohsenzadegan M; Farajollahi MM Clin Exp Pharmacol Physiol; 2022 Feb; 49(2):254-263. PubMed ID: 34699087 [TBL] [Abstract][Full Text] [Related]
13. The effects of guluronic acid (G2013), a new emerging treatment, on inflammatory factors in nonalcoholic steatohepatitis patients under Tahmasebi S; Neishaboori H; Jafari D; Faghihzadeh E; Esmaeilzadeh A; Mirshafiey A Immunopharmacol Immunotoxicol; 2021 Oct; 43(5):562-570. PubMed ID: 34314306 [TBL] [Abstract][Full Text] [Related]
14. Liposomal pravastatin inhibits tumor growth by targeting cancer-related inflammation. Coimbra M; Banciu M; Fens MH; de Smet L; Cabaj M; Metselaar JM; Storm G; Schiffelers RM J Control Release; 2010 Dec; 148(3):303-10. PubMed ID: 20869410 [TBL] [Abstract][Full Text] [Related]
15. Clostridium difficile toxin B recombinant protein inhibits tumor growth and induces apoptosis through inhibiting Bcl-2 expression, triggering inflammatory responses and activating C-erbB-2 and Cox-2 expression in breast cancer mouse model. Zhang Y; Li Y; Li H; Chen W; Liu W Biomed Pharmacother; 2018 May; 101():391-398. PubMed ID: 29501042 [TBL] [Abstract][Full Text] [Related]
16. Influencing COX-2 Activity by COX Related Pathways in Inflammation and Cancer. Yu T; Lao X; Zheng H Mini Rev Med Chem; 2016; 16(15):1230-1243. PubMed ID: 27145850 [TBL] [Abstract][Full Text] [Related]
17. Docosahexaenoic acid suppresses breast cancer cell metastasis by targeting matrix-metalloproteinases. Yun EJ; Song KS; Shin S; Kim S; Heo JY; Kweon GR; Wu T; Park JI; Lim K Oncotarget; 2016 Aug; 7(31):49961-49971. PubMed ID: 27363023 [TBL] [Abstract][Full Text] [Related]
18. Anti-inflammatory and antitumoural effects of Uncaria guianensis bark. Urdanibia I; Michelangeli F; Ruiz MC; Milano B; Taylor P J Ethnopharmacol; 2013 Dec; 150(3):1154-62. PubMed ID: 24212077 [TBL] [Abstract][Full Text] [Related]
19. PH006, a novel and selective Src kinase inhibitor, suppresses human breast cancer growth and metastasis in vitro and in vivo. Ma JG; Huang H; Chen SM; Chen Y; Xin XL; Lin LP; Ding J; Liu H; Meng LH Breast Cancer Res Treat; 2011 Nov; 130(1):85-96. PubMed ID: 21181437 [TBL] [Abstract][Full Text] [Related]
20. In Vivo Anti-Tumor Effects of Flavokawain A in 4T1 Breast Cancer Cell-Challenged Mice. Abu N; Mohamed NE; Yeap SK; Lim KL; Akhtar MN; Zulfadli AJ; Kee BB; Abdullah MP; Omar AR; Alitheen NB Anticancer Agents Med Chem; 2015; 15(7):905-15. PubMed ID: 26179368 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]